论文部分内容阅读
目的:针对儿科重症感染患者采取不同剂量肾上腺皮质激素联合抗感染药物治疗,根据肾上腺皮质激素联合抗感染药物治疗的治疗结果对其应用价值进行分析。方法:本院所接收儿科重症感染患者80例均来源于2014年1月至2016年12月中院内所接收的患者。将80例儿科重症感染患者均分为4组,其中20例患者为参照组(A组),剩余60例患者以20例患者为一个梯度均分为大量药剂组(B组)、中等药剂组(C组)、少量药剂组(D组)。A组的患者进行常规性(即药物治疗)的治疗工作,对B、C、D组的患者在常规性治疗的基础上还采取不同剂量肾上腺皮质激素治疗。结果:B、C、D组实施联合药物治疗重症感染患者的疗效明显要高于A组采取常规治疗重症感染患者的疗效。B、C、D组中重症感染患者的治疗效果没有较大的差异。结论:对重症感染患者采取肾上腺皮质激素联合药物治疗,提高患者的康复速度,能将不良反应发生的可能性降至最低,有利于患者的身心健康。
Objective: To treat patients with severe pediatric infections with different doses of adrenal cortical hormone combined with anti-infective drug therapy, according to adrenal cortical hormone combined with anti-infective drug treatment results of its application value analysis. Methods: All of the 80 patients receiving pediatric severe infectious diseases in our hospital were from the patients received in the middle hospital from January 2014 to December 2016. Eighty patients with severe pediatric infection were divided into four groups, of which 20 patients were in the reference group (group A), and the remaining 60 patients were divided into a large number of groups (group B) with a gradient of 20 patients, (C group), a small amount of drug group (D group). Patients in group A were treated routinely (ie drug treatment), and patients in groups B, C and D received different doses of corticosteroids on a routine basis. Results: The efficacy of combination therapy in patients with severe infections in groups B, C and D was significantly higher than that in patients in group A treated with conventional treatment of severe infections. B, C, D group of patients with severe infections no significant difference in the treatment effect. Conclusion: Adverse cortical hormone therapy combined with drug therapy for patients with severe infections can improve the recovery rate of patients and minimize the possibility of adverse reactions, which is good for the patients’ physical and psychological health.